We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+13.24%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.44B
AUM Growth
-$133M
(-5.2%)
Cap. Flow
-$77.2M
Cap. Flow
% of AUM
-3.16%
Top 10 Holdings %
Top 10 Hldgs %
50.14%
Holding
73
New
3
Increased
9
Reduced
33
Closed
4
Top Buys
| 1 |
AKRO
Akero Therapeutics
AKRO
|
+$44.6M |
| 2 |
Prime Medicine
PRME
|
+$39.9M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$34.8M |
| 4 |
Replimune Group
REPL
|
+$24.7M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$23.5M |
Top Sells
| 1 |
argenx
ARGX
|
+$49.2M |
| 2 |
Prothena Corp
PRTA
|
+$31.9M |
| 3 |
ONEM
1Life Healthcare
ONEM
|
+$29.7M |
| 4 |
SkinHealth Systems
SKIN
|
+$24.9M |
| 5 |
LivaNova
LIVN
|
+$22M |
Sector Composition
| 1 | Healthcare | 98.91% |
| 2 | Industrials | 0.92% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTYX
26
DELISTED
Ventyx Biosciences
VTYX
| $29.3M | 1.2% |
894,974
-470,026
| -34% | -$13.9M |
|
27
ADC Therapeutics
ADCT
$162M
| $29.1M | 1.19% |
7,590,849
+78,820
| +1% | +$315K |
|
28
Stryker
SYK
$121B
| $25.9M | 1.06% |
105,880
-51,441
| -33% | -$11.7M |
|
29
Entrada Therapeutics
TRDA
$270M
| $25.1M | 1.03% |
1,854,108
-100,311
| -5% | -$1.76M |
|
|
GRTS
30
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $23.9M | 0.98% |
6,931,460
-21,300
| -0.3% | -$60.8K |
|
|
VERV
31
DELISTED
Verve Therapeutics
VERV
| $23.6M | 0.97% |
1,221,903
-283,223
| -19% | -$7.5M |
|
32
Centene
CNC
$33B
| $23.1M | 0.94% |
281,260
-1,200
| -0.4% | -$98K |
|
|
AUGX
33
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $22.4M | 0.92% |
14,380,327
| – | – |
|
|
ALLK
34
DELISTED
Allakos
ALLK
| $21.4M | 0.88% |
2,545,275
| – | – |
|
35
Atara Biotherapeutics
ATRA
$76.6M
| $20.5M | 0.84% |
249,710
| – | – |
|
36
Elevance Health
ELV
$85.1B
| $20M | 0.82% |
38,970
-31,517
| -45% | -$16M |
|
37
Immunovant
IMVT
$8.1B
| $19.3M | 0.79% |
+1,088,131
| New | +$13.7M |
|
38
Scholar Rock
SRRK
$6.44B
| $19M | 0.78% |
2,095,820
-1,044,206
| -33% | -$8.38M |
|
39
Annexon
ANNX
$990M
| $18.1M | 0.74% |
3,503,190
| – | – |
|
40
Stevanato
STVN
$5.36B
| $16.9M | 0.69% |
942,525
-4,300
| -0.5% | -$71.3K |
|
41
Absci
ABSI
$1.67B
| $16.9M | 0.69% |
8,031,094
| – | – |
|
|
RAPT
42
DELISTED
RAPT Therapeutics
RAPT
| $15.5M | 0.64% |
98,104
| – | – |
|
43
Revolution Medicines
RVMD
$39.3B
| $14.9M | 0.61% |
625,000
| – | – |
|
44
Shattuck Labs
STTK
$609M
| $12.9M | 0.53% |
5,619,914
| – | – |
|
|
MDVL
45
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $10.4M | 0.42% |
692,090
| – | – |
|
46
Ionis Pharmaceuticals
IONS
$9.03B
| $10.1M | 0.41% |
266,187
-141,472
| -35% | -$5.95M |
|
|
LVTX
47
DELISTED
LAVA Therapeutics
LVTX
| $9.86M | 0.4% |
2,816,196
| – | – |
|
|
KLRS
48
Kalaris Therapeutics
KLRS
$110M
| $9.79M | 0.4% |
82,955
| – | – |
|
|
SNCE
49
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $8.22M | 0.34% |
990,412
| – | – |
|
50
ALX Oncology
ALXO
$270M
| $6.85M | 0.28% |
607,470
-144,627
| -19% | -$1.62M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO